Amedisys

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Amedisys reports robust Q4 earnings, eyes growth amidst operational challenges

Amedisys showcases strong financial performance and strategic initiatives for 2023, focusing on growth and operational optimization.
Despite challenges like labor market issues and operational hurdles, the company remains confident in its growth strategies and talent management.
Opportunities in negotiations with payers, talent acquisition, and operational enhancements position Amedisys for continued success and revenue growth.
With a positive outlook for 2023 and a resilient approach to challenges, Amedisys is poised for steady growth and operational improvements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

Amedisys (AMED) continues to benefit from the recent acquisitions of hospice care providers.

Amedisys (AMED) Banks on Home Health & Hospice Amid Cost Woe

BATON ROUGE, La., Nov. 10, 2020 (GLOBE NEWSWIRE) --  Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Stephens Annual Investment Conference 2020 on Thursday, November 19, 2020.

Amedisys to Present at the Stephens Annual Investment Conference 2020

BATON ROUGE, La., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on Tuesday, November 10, 2020.

Amedisys to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

Amedisys, Inc. (AMED) CEO Paul Kusserow on Q3 2020 Results - Earnings Call Transcript

Amedisys (AMED) possesses solid growth attributes, which could help it handily outperform the market.

3 Reasons Why Amedisys (AMED) Is a Great Growth Stock

An impressive Q3 performance by Amedisys' (AMED) Home health and hospice amid the pandemic-led business disruptions buoys optimism.

Amedisys (AMED) Beats Q3 Earnings Estimates, Ups 2020 View

Amedisys, Inc.'s (AMED) CEO Paul Kusserow on Q3 2020 Results - Earnings Call Transcript

After a 82% rise since the March 16 lows of this year, at the current price of around $249 per share we believe Amedisys stock, a home health and hospice care company, has reached its near-term potential. AMED stock has rallied from $137 to $249 off the recent bottom compared to the S&P.

Despite A Q3 Beat The Rally In Amedisys Stock Appears Overdone

Amedisys (AMED) delivered earnings and revenue surprises of 76.38% and 2.06%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Amedisys (AMED) Tops Q3 Earnings and Revenue Estimates

Shares of Amedisys (NASDAQ:AMED) fell 2.7% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 94.78% year over year to $2.24, which beat the estimate of $1.28.

Amedisys: Q3 Earnings Insights

BATON ROUGE, La., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2020.

Amedisys Reports Third Quarter 2020 Financial Results - Updates 2020 Guidance

CVS Health

Meritage Homes

Insperity

Vertex Pharmaceuticals

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Meritage Homes (MTH), Vertex Pharmaceuticals (VRTX), CVS Health (CVS), Amedisys (AMED) and Insperity (NSP) are sound enough to meet financial obligations.

Pick These 5 Stocks With Superb Interest Coverage Ratio

BATON ROUGE, La., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the third quarter ended September 30, 2020, after the market closes on October 28, 2020. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on October 29, 2020.

Amedisys Announces Third Quarter Earnings Release and Conference Call Date

Amedisys (AMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Amedisys (AMED) Upgraded to Buy: Here's What You Should Know

BATON ROUGE, La., Aug.  31, 2020  (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Baird 2020 Global Healthcare Conference on Thursday, September 10, 2020.

Amedisys to Present at the Baird 2020 Global Healthcare Conference

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

Why Is Amedisys (AMED) Up 6.4% Since Last Earnings Report?

Amedisys (AMED) strengthens Personal Care business reach by entering into an agreement with BrightStar.

Amedisys & BrightStar Ink Agreement to Expand Personal Care

BATON ROUGE, La., Aug.  24, 2020  (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, has signed a Care Coordination Agreement with BrightStar Care to add its agencies to the Amedisys Personal Care Network, which helps facilitate the coordination of care between Amedisys’ hospice and home health care centers and a network of personal care partners.

Amedisys Expands Personal Care Network with BrightStar Care

Amedisys (AMED) has been benefiting from the recent acquisitions of hospice care providers.

Amedisys Banks on Coronavirus-Driven Growth Amid Cost Woes

Amedisys, Inc. (AMED) CEO Paul Kusserow on Q2 2020 Results - Earnings Call Transcript

Amedisys' (AMED) second-quarter results reflect impressive performance by the Hospice division despite pandemic-led challenges.

Amedisys (AMED) Earnings and Revenues Beat Estimates in Q2

Shares of Amedisys (NASDAQ:AMED) were flat in after-market trading after the company reported Q2 results.

Recap: Amedisys Q2 Earnings

Amedisys (AMED) delivered earnings and revenue surprises of 69.62% and 4.30%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Amedisys (AMED) Surpasses Q2 Earnings and Revenue Estimates

BATON ROUGE, La., July  28, 2020  (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month period ended June 30, 2020.

Amedisys Reports Second Quarter 2020 Financial Results - Reissues 2020 Guidance

Amedisys (AMED) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

News for Amedisys Stock (AMED)